Corrigendum: Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements [Rheumatology, 54, (2015) (2230-2238)] DOI: 10.1093/rheumatology/kev200;Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Rheumatology (United Kingdom)

Volumn 54, Issue 12, 2015, Pages 2230-2238

  Ramos Casals, Manuel ^a   Brito Zerón, Pilar ^a   Seror, Raphaèle ^b   Bootsma, Hendrika ^c   Bowman, Simon J ^d   Dörner, Thomas ^e   Gottenberg, Jacques Eric ^f   Mariette, Xavier ^b   Theander, Elke ^g   Bombardieri, Stefano ^h   Vita, Salvatore De ⁱ   Mandl, Thomas ^g   Ng, Wan Fai ^j   Kruize, Aike ^k   Tzioufas, Athanasios ^l   Vitali, Claudio ^m  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF PISA   (Italy)

ⁱ SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m Instituto San Giuseppe   (Italy)

more..

Author keywords

Annular erythema; Arthritis; Bronchial disease; Extraglandular features; Glomerulonephritis; Interstitial lung disease; Interstitial nephritis; Primary Sj gren's syndrome; Tubular renal acidosis; Vasculitis

Indexed keywords

ADULT; ANNULAR ERYTHEMA; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; ARTICLE; CLINICAL FEATURE; CONSENSUS; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; EULAR SS DISEASE ACTIVITY INDEX; EUROPE; EVIDENCE BASED MEDICINE; FEMALE; GLOMERULOPATHY; HUMAN; LUNG DISEASE; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC DISEASE; VASCULITIS;

EID: 84983156742     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kex157     Document Type: Erratum

References (27)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012;344:e3821.
2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275-84.
3. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-54.
4. Seror R, Theander E, Brun JG et al. Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015;74:859-66.
5. Seror R, Ravaud P, Mariette X et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968-72.
6. Seror R, Theander E, Bootsma H et al. Outcome measures for primary Sjögren's syndrome: a comprehensive review. J Autoimmun 2014;51:51-6.
7. Ramos-Casals M, Brito-Zerón P, Font J. The overlap of Sjögren's syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum 2007;36:246-55.
8. Brito-Zerón P, Retamozo S, Akasbi M et al. Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases. Lupus 2014;23:166-75.
9. Katayama I, Kotobuki Y, Kiyohara E, Murota H. Annular erythema associated with Sjögren's syndrome: review of the literature on the management and clinical analysis of skin lesions. Mod Rheumatol 2010;20:123-9.
10. Soto-Cardenas MJ, Perez-De-Lis M, Bove A et al. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance. Clin Exp Rheumatol 2010;28:647-53.
11. Enomoto Y, Takemura T, Hagiwara E et al. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One 2013;8:e73774.
12. Reddy P. Clinical approach to renal tubular acidosis in adult patients. Int J Clin Pract 2011;65:350-60.
13. Maripuri S, Grande JP, Osborn TG et al. Renal involvement in primary Sjögren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 2009;4:1423-31.
14. Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum 2013;65:2945-53.
15. Natsuga K, Sawamura D, Homma E et al. Amicrobial pustulosis associated with IgA nephropathy and Sjögren's syndrome. J Am Acad Dermatol 2007;57:523-6.
16. Lim YL, Ng SK, Lian TY. Amicrobial pustulosis associated with autoimmune disease in a patient with Sjögren syndrome and IgA nephropathy. Clin Exp Dermatol 2012;37:374-8.
17. Ramos-Casals M, Brito-Zerón P, Solans R et al. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 2014;53:321-31.
18. Seror R, Gottenberg JE, Devauchelle-Pensec V et al. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient- Reported Index: a complete picture of primary Sjögren's syndrome patients. Arthritis Care Res 2013;65:1358-64.
19. Baldini C, Pepe P, Quartuccio L et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 2014;53:839-44.
20. van der Heijde D, van der Helm-van Mil AH, Aletaha D et al. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis 2013;72:479-81.
21. Ramos-Casals M, Anaya JM, García-Carrasco M et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine 2004;83:96-106.
22. Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
23. Hurst JW. The value of using the entire New York Heart Association's classification of heart and vascular disease. Clin Cardiol 2006;29:415-7.
24. Travis WD, Costabel U, Hansell DM et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48.
25. Chadban SJ, Atkins RC. Glomerulonephritis. Lancet 2005;365:1797-806.
26. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012;379:348-60.
27. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51.